Clinical Trial Update: Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase II trial evaluating topical tacrolimus 0.1% ointment for cutaneous Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Topical Tacrolimus 0.1% Ointment (Tacrolimus)

Snippet

Sponsor: University of Aberdeen | Conditions: Crohn Disease | Phase 2 | Status: COMPLETED